Advance Notice: EastPharma Ltd Sales Update Announcement for the period 31 March 2016


London, 25 April 2016 - EastPharma (EAST LI)  informs that it will be releasing its Q1 2016 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the related period on 5 May 2016.

A conference call to review the Q1 2016 sales performance will be hosted by the management of EastPharma at 12:00-noon London time on 6 May 2016 (07:00am New York / 01:00pm Zurich time / 02:00pm Istanbul time). The dial-in details are provided below.

Conference call:

Dial-in Number (UK): + 44 (0)207 1620 177
Dial-in Number (US): + 1 334 323 6203
Dial-in Number (Switzerland): + 41 (0)434 5692 63
Dial-in Number (Germany): + 49 (0)695 8999 0509

Conference ID:  958508

For further information, please contact:

Investor Relations:

EastPharma Ltd -  a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit .

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: EastPharma Ltd via GlobeNewswire